Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
P01AB01	PHOZOLE	G	Metronidazole benzoate - 125mg/5ml	125mg/5ml	Suspension	207,336 L.L
P01AB01	POLGYL	G	Metronidazole - 0.5%	0.50%	Injectable solution	134,384 L.L
N06BA09	PMS-ATOMOXETINE	G	Atomoxetine (HCl) - 60mg	60mg	Capsule	5,228,891 L.L
N06BA09	PMS-ATOMOXETINE	G	Atomoxetine (HCl) - 40mg	40mg	Capsule	4,706,136 L.L
N06BA09	PMS-ATOMOXETINE	G	Atomoxetine (HCl) - 25mg	25mg	Capsule	4,121,565 L.L
N06BA09	PMS-ATOMOXETINE	G	Atomoxetine (HCl) - 18mg	18mg	Capsule	3,744,073 L.L
N06AX21	PMS-DULOXETINE	G	Duloxetine HCl - 60mg	60mg	Capsule, delayed release	976,973 L.L
N06AX21	PMS-DULOXETINE	G	Duloxetine HCl - 30mg	30mg	Capsule, delayed release	642,357 L.L
N06AB10	PRAMACYT 10	G	Escitalopram (oxalate) - 10mg	10mg	Tablet, film coated	767,910 L.L
N06AB10	PRYLEX 10	G	Escitalopram (oxalate) - 10mg	10mg	Tablet, film coated	767,910 L.L
N06AB10	PRAMACYT 15	G	Escitalopram (oxalate) - 15mg	15mg	Tablet, film coated	921,492 L.L
N06AB10	PRYLEX 15	G	Escitalopram (oxalate) - 15mg	15mg	Tablet, film coated	921,492 L.L
N06AB10	PRAMACYT 20	G	Escitalopram (oxalate) - 20mg	20mg	Tablet, film coated	972,686 L.L
N06AB10	PRYLEX 20	G	Escitalopram (oxalate) - 20mg	20mg	Tablet, film coated	972,686 L.L
N06AB10	PRAMACYT 5	G	Escitalopram (oxalate) - 5mg	5mg	Tablet, film coated	895,895 L.L
N06AB10	PRYLEX 5	G	Escitalopram (oxalate) - 5mg	5mg	Tablet, film coated	895,895 L.L
N06AB06	PMS-SERTRALINE	G	Sertraline HCl - 100mg	100mg	Capsule	2,015,764 L.L
N06AB05	PARLOTIN	G	Paroxetine (HCl) - 20mg	20mg	Tablet	894,999 L.L
N06AB05	PAXERA	G	Paroxetine (HCl) - 20mg	20mg	Tablet, film-scored	1,016,841 L.L
N06AB05	PMS-PAROXETINE	G	Paroxetine (HCl) - 20mg	20mg	Tablet	731,050 L.L
N06AB03	PMS-FLUOXETINE	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	592,635 L.L
N06AB03	PROXETIN	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	374,996 L.L
N05CM18	PRECEDEX (DEXMEDETOMIDINE)	B	Dexmedetomidine HCl - 200mcg/2ml	200mcg/2ml	Injectable solution	19,441,512 L.L
N05CM18	PROXIDA	G	Dexmedetomidine HCl - 200mcg/2ml	200mcg/2ml	Injectable concentrate for solution	1,771,184 L.L
N05BA12	PAZOLAM	G	Alprazolam - 0.5mg	0.5mg	Tablet	563,070 L.L
N05BA02	PSICODEX	G	Chlordiazepoxide - 5mg	5mg	Tablet	152,302 L.L
N05AX12	PIRIFY	G	Aripiprazole - 10mg	10mg	Tablet	795,555 L.L
N05AX12	PIRIFY	G	Aripiprazole - 15mg	15mg	Tablet	795,555 L.L
N05AX12	PIRIFY	G	Aripiprazole - 5mg	5mg	Tablet	614,328 L.L
N05AX08	PMS-RISPERIDONE	G	Risperidone - 1mg	1mg	Tablet	823,775 L.L

...